Drug Shortage Report for ATROPINE SULFATE INJECTION USP
Report ID | 173235 |
Drug Identification Number | 00328154 |
Brand name | ATROPINE SULFATE INJECTION USP |
Common or Proper name | ATROPINE SULFATE INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ATROPINE SULFATE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 10 x 10mL LifeShield syringes |
ATC code | A03BA |
ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-14 |
Estimated end date | |
Actual end date | 2023-02-03 |
Shortage status | Resolved |
Updated date | 2023-02-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-11-01 | English | Compare |
v2 | 2022-11-01 | French | Compare |
v3 | 2022-12-14 | English | Compare |
v4 | 2022-12-14 | French | Compare |
v5 | 2022-12-15 | English | Compare |
v6 | 2023-01-31 | English | Compare |
v7 | 2023-01-31 | French | Compare |
v8 | 2023-02-03 | English | Compare |
v9 | 2023-02-03 | French | Compare |
v10 | 2023-02-04 | English | Compare |
Showing 1 to 10 of 10